LOSS- Louisiana Obese Subjects Study

NCT00115063 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

390

Enrollment

OTHER

Sponsor class

Stopped ethical issues of continuing control group without treatment

Conditions

Obesity

Interventions

BEHAVIORAL: group sessions
DRUG: sibutramine, orlistat, diethylpropion
BEHAVIORAL: Low Calorie Diet, Health One
OTHER: Intensive Medical Combination Therapy for Obesity
OTHER: Control Condition

Sponsor

Pennington Biomedical Research Center

Collaborators

[object Object]